Steris PLC (BSP:S1TE34)
R$ 60 6.95 (13.1%) Market Cap: 118.58 Bil Enterprise Value: 133.52 Bil PE Ratio: 61.78 PB Ratio: 3.69 GF Score: 33/100

Steris plc at Needham Virtual Growth Conference Transcript

Jan 11, 2021 / 08:30PM GMT
Release Date Price: R$55.11 (+3.22%)
Michael Stephen Matson
Needham & Company, LLC, Research Division - Senior Analyst

All right. Good afternoon. I'm Mike Matson, Senior Medical Device Analyst with Needham & Company. Thanks for joining us for the 23rd Annual Needham Growth Conference.

I have STERIS presenting now. From STERIS, we have Walter Rosebrough, CEO; and Julie Winter, VP of IR.

Questions & Answers

Michael Stephen Matson
Needham & Company, LLC, Research Division - Senior Analyst

So we're going to go straight into the Q&A here. I'm going to start out like I have with some of the other companies that we've done fireside chats with: I wanted you to talk about bigger picture here in 2021 as we start to have the vaccines roll out across the U.S. and globally. How are you thinking about the recovery in your business as people increasingly get vaccinated and things start to kind of normalize?

Walter M. Rosebrough
STERIS plc - CEO, President & Director

Sure, Mike. First of all, I think most of us expected to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot